SenSen Networks Limited - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Read More

Technology Industry News

SenSen Networks (ASX: SNS) surges 41% after FY25 turnaround: Is this small-cap AI stock finally scaling?

SenSen Networks (ASX: SNS) posts a profitable FY25 with strong North America traction and AI momentum. Discover why investors are finally taking notice.

byPallavi Madhiraju

September 3, 2025

web analytics